Literature DB >> 8393861

Functional nonequivalence of structurally homologous domains of neurokinin-1 and neurokinin-2 type tachykinin receptors.

P Blount1, J E Krause.   

Abstract

The neurokinin-1 (NK-1) and neurokinin-2 (NK-2) receptors are both members of the tachykinin receptor family. Although both receptors bind peptide ligands synthesized from common precursors and activate inositol 1,4,5-triphosphate and cAMP responses, differences between these receptors have been observed in the extent and kinetics of agonist-induced responses. Here, to test if structurally homologous domains of the NK-1 and NK-2 receptors are functionally distinct, stably transfected Chinese hamster ovary (CHO) cell lines expressing receptors that had either their putative third cytoplasmic loop (C3) or carboxyl tail (CT) domains replaced with the equivalent domain of the other receptor were compared with stably transfected CHO cell lines expressing wild-type receptors. Radioligand binding demonstrated that each of these chimeric receptors had agonist binding affinities indistinguishable from wild-type receptors. However, not all chimeric receptors were equivalent in their ability to stimulate inositol phospholipid turnover and cAMP production. The data suggest that the NK-1 C3 and the NK-2 CT domains play important roles in G-protein activation that cannot be replaced by the analogous domain of the other receptor. The characterization of CHO cell lines expressing truncated forms of both receptors supported the hypothesis that the CT domain of the NK-2, but not the NK-1, receptor plays a critical role in G-protein activation. The data suggest a potential mechanism for the differences observed in response characteristics in tissues expressing NK-1 and NK-2 receptors and demonstrate that the mechanisms whereby highly homologous receptors activate G-proteins can be different.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8393861

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  A substance P (neurokinin-1) receptor mutant carboxyl-terminally truncated to resemble a naturally occurring receptor isoform displays enhanced responsiveness and resistance to desensitization.

Authors:  H Li; S E Leeman; B E Slack; G Hauser; W S Saltsman; J E Krause; J K Blusztajn; N D Boyd
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 2.  Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.

Authors:  Steven D Douglas; Susan E Leeman
Journal:  Ann N Y Acad Sci       Date:  2010-11-22       Impact factor: 5.691

3.  The mechanosensitive channel of small conductance (MscS) functions as a Jack-in-the box.

Authors:  Hannah R Malcolm; Paul Blount; Joshua A Maurer
Journal:  Biochim Biophys Acta       Date:  2014-10-23

4.  Chimeras reveal a single lipid-interface residue that controls MscL channel kinetics as well as mechanosensitivity.

Authors:  Li-Min Yang; Dalian Zhong; Paul Blount
Journal:  Cell Rep       Date:  2013-02-14       Impact factor: 9.423

5.  Sensitization of spinal cord nociceptive neurons with a conjugate of substance P and cholera toxin.

Authors:  Robert M Caudle; Andrew J Mannes; Jason Keller; Federico M Perez; Shelby K Suckow; John K Neubert
Journal:  BMC Neurosci       Date:  2007-05-10       Impact factor: 3.288

6.  Novel compounds that specifically bind and modulate MscL: insights into channel gating mechanisms.

Authors:  Robin Wray; Irene Iscla; Zoltan Kovacs; Junmei Wang; Paul Blount
Journal:  FASEB J       Date:  2018-10-25       Impact factor: 5.834

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.